Bevaas 100

Bevacizumab, is a medication used to treat a number of types of cancers and a specific eye disease.
For cancer it is given by slow injection into a vein and used for colon cancer, lung cancer, glioblastoma, and renal-cell carcinoma.

Bevaas is Hetero’s second monoclonal antibody and the third biosimilar product, that is offering major relief for conditions such as Metastatic Colorectal Cancer, Lung Cancer and Renal Cancer.